DE69733329D1 - Verwendung von Taurin zur Behandlung oder Vorbeugung von ischämischen Verletzungen - Google Patents

Verwendung von Taurin zur Behandlung oder Vorbeugung von ischämischen Verletzungen

Info

Publication number
DE69733329D1
DE69733329D1 DE69733329T DE69733329T DE69733329D1 DE 69733329 D1 DE69733329 D1 DE 69733329D1 DE 69733329 T DE69733329 T DE 69733329T DE 69733329 T DE69733329 T DE 69733329T DE 69733329 D1 DE69733329 D1 DE 69733329D1
Authority
DE
Germany
Prior art keywords
taurine
prevention
treatment
ischemic injuries
ischemic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69733329T
Other languages
English (en)
Other versions
DE69733329T2 (de
Inventor
Tadaomi Miyamoto
Koho Miyamoto
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Meddiss Inc
Original Assignee
Meddiss Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Meddiss Inc filed Critical Meddiss Inc
Publication of DE69733329D1 publication Critical patent/DE69733329D1/de
Application granted granted Critical
Publication of DE69733329T2 publication Critical patent/DE69733329T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid, pantothenic acid
    • A61K31/198—Alpha-aminoacids, e.g. alanine, edetic acids [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Cardiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE69733329T 1996-03-26 1997-03-21 Verwendung von Taurin zur Behandlung oder Vorbeugung von ischämischen Verletzungen Expired - Lifetime DE69733329T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US62260696A 1996-03-26 1996-03-26
US622606 1996-03-26

Publications (2)

Publication Number Publication Date
DE69733329D1 true DE69733329D1 (de) 2005-06-30
DE69733329T2 DE69733329T2 (de) 2006-02-02

Family

ID=24494811

Family Applications (2)

Application Number Title Priority Date Filing Date
DE69733329T Expired - Lifetime DE69733329T2 (de) 1996-03-26 1997-03-21 Verwendung von Taurin zur Behandlung oder Vorbeugung von ischämischen Verletzungen
DE69739306T Expired - Lifetime DE69739306D1 (de) 1996-03-26 1997-03-21 Verwendung von Taurin, Homotaurin und/oder Methionin zur Erzeugung von Narkose.

Family Applications After (1)

Application Number Title Priority Date Filing Date
DE69739306T Expired - Lifetime DE69739306D1 (de) 1996-03-26 1997-03-21 Verwendung von Taurin, Homotaurin und/oder Methionin zur Erzeugung von Narkose.

Country Status (6)

Country Link
US (2) US6015835A (de)
EP (2) EP1473032B1 (de)
JP (1) JPH1045578A (de)
AU (1) AU703540B2 (de)
CA (1) CA2200795C (de)
DE (2) DE69733329T2 (de)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040208875A1 (en) 1995-03-15 2004-10-21 Queen's University At Kingston Method for treating amyloidosis
FR2772271B1 (fr) * 1997-12-11 2000-09-01 Union Pharma Scient Appl Nouvelle association pharmaceutique a activite analgesique
US20020022657A1 (en) * 1998-02-11 2002-02-21 Francine Gervais Methods for modulating neuronal cell death
IT1298758B1 (it) * 1998-03-19 2000-02-02 Angelini Ricerche Spa Soluzione umettante e lubrificante per uso oftalmico
EP1023843B1 (de) * 1999-01-29 2005-06-22 Sportmedizin Team Vertriebs GmbH Zusammensetzung zur Leistungsförderung bei sportlicher Tätigkeit, ihre Herstellung und Verwendung als diätetisches Lebensmittel
CN100482233C (zh) * 1999-04-28 2009-04-29 贝卢斯健康(国际）有限公司 用于治疗淀粉样变性的组合物和方法
US6562836B1 (en) 1999-05-24 2003-05-13 Queen's University Of Kingston Methods and compounds for inhibiting amyloid deposits
CA2320556A1 (en) 1999-09-29 2001-03-29 Queen's University At Kingston N,n-dichlorinated omega amino acids and uses thereof
AU2001261244B2 (en) * 2000-05-09 2006-08-03 Nitromed, Inc. Infrared thermography and methods of use
EP1256360A1 (de) * 2001-05-10 2002-11-13 Université de Liège Hypertonisches Medikament insbesondere zur Verwendung in der Flüssigkeitstherapie
JP5084089B2 (ja) * 2001-06-14 2012-11-28 大塚製薬株式会社 医薬組成物
JP5028639B2 (ja) * 2001-08-02 2012-09-19 成男 太田 ミトコンドリア病の予防又は治療薬
FR2833839A1 (fr) * 2001-12-21 2003-06-27 Rytek Methodes et compositions pour le traitement de pathologies respiratoires
FR2833840B1 (fr) * 2001-12-21 2010-06-18 Rytek Methodes et compositions pour le traitement de pathologies respiratoires
US7452877B2 (en) 2002-03-15 2008-11-18 Rytek Methods for treating digestive functional pathologies
FR2844201A1 (fr) * 2002-09-06 2004-03-12 Rytek Compositions pour le traitement de pathologies fonctionnelles digestives
FR2837103B1 (fr) * 2002-03-15 2004-07-09 Rytek Compositions pour le traitement de pathologies fonctionelles digestives
US20070010573A1 (en) 2003-06-23 2007-01-11 Xianqi Kong Methods and compositions for treating amyloid-related diseases
US20050142191A1 (en) 2003-06-23 2005-06-30 Neurochem (International) Limited Pharmaceutical formulations of amyloid inhibiting compounds
US7244764B2 (en) * 2003-06-23 2007-07-17 Neurochem (International) Limited Methods and compositions for treating amyloid-related diseases
US7414076B2 (en) * 2003-06-23 2008-08-19 Neurochem (International) Limited Methods and compositions for treating amyloid-related diseases
WO2005120489A2 (en) * 2004-06-04 2005-12-22 Molecular Therapeutics, Inc. Treatment of central nervous system disorders or injuries with d-methionine
CA2586111A1 (en) * 2004-11-12 2006-06-08 Neurochem (International) Limited Methods and fluorinated compositions for treating amyloid-related diseases
CA2586334A1 (en) * 2004-11-16 2006-06-08 Neurochem (International) Limited Compounds for the treatment of cns and amyloid associated diseases
FR2879100B1 (fr) 2004-12-09 2007-07-06 Lionel Bueno Compositions pour le traitement des pathologies oculaires de surface et de la retine
AU2005326962A1 (en) 2004-12-22 2006-08-17 Bellus Health (International) Limited Methods and compositions for treating amyloid-related diseases
TW200716088A (en) 2005-04-15 2007-05-01 Neurochem Int Ltd Formulations and methods for treating amyloidosis
DE602006016990D1 (de) 2005-12-22 2010-10-28 Bellus Health Int Ltd Behandlung von diabetischer nephropathie
WO2009019534A2 (en) 2006-10-12 2009-02-12 Bellus Health (International) Limited Methods, compounds, compositions and vehicles for delivering 3-amino-1-propanesulfonic acid
EP2120905A1 (de) * 2006-12-22 2009-11-25 BELLUS Health (International) Limited Verfahren, verbindungen und zusammensetzungen zur behandlung von stoffwechselerkrankungen und diabetes
US9566256B2 (en) 2008-09-22 2017-02-14 Biochemics, Inc. Transdermal drug delivery using an osmolyte and vasoactive agent
EP2349988A4 (de) * 2008-11-14 2012-05-02 Bellus Health Inc Organische nährsalze sowie verfahren zu ihrer herstellung und verwendung
FR2953411B1 (fr) * 2009-12-03 2012-02-03 Biocodex Combinaison synergique de composes analgesiques
US10918612B2 (en) * 2013-01-22 2021-02-16 Markus Zwickl Combinations with 2-aminoethanesulfonic acid
ITUA20161679A1 (it) * 2016-03-15 2017-09-15 Neuraxpharm Italy S P A Composizione per prevenire e trattare patologie neurodegenerative e disturbi cognitivi
US11865139B2 (en) 2020-11-12 2024-01-09 Thermolife International, Llc Method of treating migraines and headaches

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2457281A1 (fr) * 1979-05-23 1980-12-19 Meram Lab Nouveaux derives de l'acide 3-aminopropanesulfonique ayant une activite membranaire renforcee
US5084007A (en) * 1989-08-11 1992-01-28 Malin David H Method for chemical promotion of the effects of low current transcranial electrostimulation
JPH05505935A (ja) * 1990-02-05 1993-09-02 ボード オブ リージェンツ，ザ ユニバーシティ オブ テキサス システム ビタミン，ミネラルおよび他の有利な補給剤の徐放性処方
US5084482A (en) * 1990-04-10 1992-01-28 The Lithox Corporation Methods for inhibiting inflammatory ischemic, thrombotic and cholesterolemic disease response with methionine compounds

Also Published As

Publication number Publication date
JPH1045578A (ja) 1998-02-17
EP1473032B1 (de) 2009-03-11
EP0797992B1 (de) 2005-05-25
CA2200795A1 (en) 1997-09-26
CA2200795C (en) 2000-11-28
EP0797992A2 (de) 1997-10-01
AU1639297A (en) 1997-10-09
AU703540B2 (en) 1999-03-25
EP1473032A1 (de) 2004-11-03
DE69733329T2 (de) 2006-02-02
US6015835A (en) 2000-01-18
DE69739306D1 (de) 2009-04-23
US6316501B1 (en) 2001-11-13
EP0797992A3 (de) 1998-06-03

Similar Documents

Publication Publication Date Title
DE69733329D1 (de) Verwendung von Taurin zur Behandlung oder Vorbeugung von ischämischen Verletzungen
ATE201138T1 (de) Verwendung von anti-mikrotubuli mitteln zur behandlung und prophylaxe der multiplen sclerose
DE69806579D1 (de) Anlage zur behandlung von nahrungsmitteln
DE122009000012I1 (de) Substituierte pyrazolyl-benzolsulfonamide zur behandlung von entzundungen.
DE69726245D1 (de) Befeuchtungsgerät zur Behandlung von Atemstillstand im Schlaf
DE60114580D1 (de) Verwendung von cyanochinolinen zur behandlung oder inhibierung von dickdarmpolypen
DE69715631D1 (de) Antikonvulsive sulfamatderivate zur behandlung von fettleibigkeit
ATE214274T1 (de) Antikonvulsiva zur verwendung bei der behandlung von amyotropischer lateralsklerose
DE69435321D1 (de) Verwendung von Botulinum Toxin zur Behandlung des myofascialen Schmerzsyndroms
DE69832838D1 (de) Vorrichtung zur Aufbewahrung und/oder Behandlung von Chemikalien
ATA46794A (de) Einrichtung zur behandlung von hautzonen
DE69941566D1 (de) N-acetylhomotaurinate zur verwendung in der behandlung von hyperkinesie
DE69821667D1 (de) Kardioverter zur Behandlung von Vorhofflattern
DE69711311D1 (de) Vorrichtung zur thermischen Behandlung von Gewebe
DE69527140T2 (de) Wirkstoff zur prävention oder behandlung von osteoporose
DE59707519D1 (de) Verwendung von 1-hydroxy-2-pyridonen zur behandlung von hautinfektionen
ATE347372T1 (de) Vakzine zur behandlung von mycosen
DE29718503U1 (de) Gerät zur Behandlung von Tinitus und Hyperakusis
DE60027429D1 (de) Dihydrobenzodiazepinen und deren verwendung zur behandlung von dyslipidämien
DE69701458T2 (de) Verwendung von buckminsterfulleren zur behandlung neurotoxischer verletzungen
DE69735139D1 (de) Orthopädische anordnung zur ausrichtung von knochen oder zur behandlung von knochenbrüchen
DE69814993D1 (de) Quasi-azeotrope Mischungen auf Basis von 1,1,1,3,3,-Pentafluorobutan, Methylene Chloride und Methanol zur Behandlung von festen Oberflächen
DE68907569T2 (de) Mittel zur Behandlung oder Vorbeugung von Aids.
ATE235494T1 (de) Imino-aza-anthracyclonderivate zur behandlung von amyloidosis
DE59711240D1 (de) Verwendung von flupirtin zur therapie und prophylaxe von myokardinfarkt, schockniere und schocklunge

Legal Events

Date Code Title Description
8364 No opposition during term of opposition